Top Banner
+ Shock R-9.16.19 Chapter 67
34

Shock R-9.16

Feb 06, 2022

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Shock R-9.16

+

Shock R-9.16.19

Chapter 67

Page 2: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Shock

n Syndrome = decreased tissue perfusion and impaired cellular metabolism

n Imbalance in supply/demand for O2 and nutrients

Page 3: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Diagnostic Studies

n Thorough H & Pn No single study

n Blood studies n Elevation of lactaten Base deficit

n 12-lead ECGn Chest x-rayn Hemodynamic monitoring

Page 4: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Shock

n Classification of shockn Cardiogenic – see handout

n Hypovolemic

n Distributive

n Obstructive

Page 5: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Low Blood FlowHypovolemic Shock

n Absolute hypovolemia: loss of intravascular fluid volume n Hemorrhage

n GI loss (e.g., vomiting, diarrhea)

n Fistula drainage

n Diabetes insipidus

n Hyperglycemia

n Diuresis

Page 6: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Low Blood FlowHypovolemic Shock

n Relative hypovolemian Results when fluid volume moves out of the vascular space into

extravascular space (e.g., intracavitary space)

n Termed third spacing

Page 7: Shock R-9.16

Pathophysiology of Hypovolemic Shock

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

Page 8: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Low Blood FlowHypovolemic Shock

n Clinical manifestationsn Anxiety

n Tachypnea

n Increase in CO, heart rate

n Decrease in stroke volume, PAWP, urinary output

n If loss is >30%, blood volume is replaced

Page 9: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative CareHypovolemic Shock

n Stop loss of fluid and restoring the circulating volume

n Fluid replacement: 3:1 rule (3 mL of isotonic crystalloid for every 1 mL of estimated blood loss)

Type of fluid?

Page 10: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockNeurogenic Shock

n Hemodynamic phenomenon

n S/P 30 minutes of a spinal cord injury at the fifth thoracic (T5) vertebra or above

n Response to spinal anesthesia

n massive vasodilation, leading to pooling of blood in vessels

Page 11: Shock R-9.16

Pathophysiology of Neurogenic Shock

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

Page 12: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockNeurogenic Shock

n Clinical manifestations n Hypotension

n Bradycardia

n Temperature dysregulation (resulting in heat loss)

n Dry skin

n Poikilothermia (taking on the temperature of the environment)

Page 13: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative CareNeurogenic Shock

n In spinal cord injury: spinal stabilityn Vasopressors

n Atropine

n Fluids cautiously

n Monitor for hypothermia

Page 14: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockAnaphylactic Shock

n Acute, life-threatening hypersensitivity (allergic) reactionn Massive vasodilation

n Release of vasoactive mediators

n ↑ Capillary permeability

Page 15: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockAnaphylactic Shock

n Clinical manifestationsn Anxiety, confusion, dizziness

n Sense of impending doom

n Chest pain

n Incontinence

n Swelling of the lips and tongue, angioedema

n Wheezing, stridor

n Flushing, pruritus, urticaria

n Respiratory distress and circulatory failure

Page 16: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative CareAnaphylactic Shock

n Epinephrine

n diphenhydramine

n Maintain a patent airway n Nebulized bronchodilators

n Aerosolized epinephrine

n Endotracheal intubation or cricothyroidotomy may be necessary

Page 17: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative CareAnaphylactic Shock

n Aggressive fluid replacement

n IV corticosteroids

Page 18: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockSeptic Shock

n Sepsis: systemic inflammatory response to documented or suspected infection

n Severe sepsis = sepsis + organ dysfunction

Page 19: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockSeptic Shock

n Septic shock n hypotension despite fluid resuscitation

n hypoxia

Page 20: Shock R-9.16

Pathophysiology of Septic Shock

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

Page 21: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockSeptic Shock

n Clinical manifestationsn ↑ Coagulation and inflammation

n ↓ Fibrinolysis

n Formation of microthrombi

n Obstruction of microvasculature

n Hyperdynamic state: increased CO and decreased SVR

Page 22: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockSeptic Shock

n Three major pathophysiologic effectsn Vasodilation

n Maldistribution of blood flow

n Myocardial depression

n Decreased ejection fraction

n Ventricular dilation

Page 23: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Distributive ShockSeptic Shock

n Clinical manifestationsn Tachypnea/hyperventilation

n Temperature dysregulation

n ↓ Urine output

n Altered neurologic status

n GI dysfunction

n Respiratory failure is common

Page 24: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative CareSeptic Shock

n Code Sepsis- Protocol handout

n Fluid replacement n Hemodynamic monitoring - Target CVP (8-12 mm Hg)

n Vasopressor drug therapy (CVP >8mm hg)

n Vasopressin for patients refractory to vasopressor therapy

n IV corticosteroids if vasopressor therapy not able to maintain BP

Page 25: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative Care Septic Shock

n Antibiotics after cultures are obtained (e.g., blood, wound exudate, urine, stool, sputum)

n 1st Broad-spectrum antibiotics

n More specific antibiotics are then given based on the organism identified

Page 26: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative Care Septic Shock

n Glucose levels <180 mg/dL

n Stress ulcer prophylaxis with histamine (H2)-receptor blockers

n DVT prophylaxis with low-dose unfractionated heparin or low-molecular-weight heparin

Page 27: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative Care

n Cornerstone of therapy for septic, hypovolemic, and anaphylactic shock = volume expansion n Isotonic crystalloids (e.g., normal saline) for initial resuscitation of shock

Page 28: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative Care

n Volume expansion- If no response to 2–3 L of crystalloids n blood administration

n CVP

n Monitor for Complications of fluid resuscitation

n Hypothermia

n Coagulopathy

Page 29: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative Care

n Primary goal of drug therapy = correction of decreased tissue perfusionn Vasopressor drugs (e.g., norepinephrine)

n Achieve/maintain MAP >60 to 65 mm Hg

n unresponsive to fluid resuscitation

n Continuously monitor end-organ perfusion

n Vasodilator therapy (e.g., nitroglycerin, nitroprusside)

n Achieve/maintain MAP >65 mm Hg

Page 30: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Collaborative Care

n Nutrition is vital to decreasing morbidity n Initiate enteral nutrition within the first 24 hours

n Initiate parenteral nutrition if enteral nutrition contraindicated or fails to meet at least 80% of caloric requirements

n Monitor protein, nitrogen balance, BUN, glucose, electrolytes

Page 31: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+Nursing Assessment

n ABCs n Airway

n Breathing

n Circulation

Page 32: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+

When assessing a patient in shock, the nurse recognizes that the hemodynamics of shock include:

a. Normal cardiac output in cardiogenic shock.

b. Increase in central venous pressure in hypovolemic shock.

c. Increase in systemic vascular resistance in all types of shock.

d. Variations in cardiac output and decreased systemic vascular resistance in septic shock.

Audience Response Question

Page 33: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+

The nurse is caring for a critically ill patient. The nurse suspects that the patient has progressed beyond the compensatory stage of shock if what occurs?

a. Increased blood glucose levelsb. Increased serum sodium levelsc. Increased serum calcium levelsd. Increased serum potassium levels

Audience Response Question

Page 34: Shock R-9.16

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

+

The nurse is caring for a patient in septic shock. Which hemodynamic change would the nurse expect?

a. Increased ejection fraction.b. Increased mean arterial pressure.c. Decreased central venous pressure.d. Decreased systemic vascular resistance.

Audience Response Question